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THE FOURTH CRITERION
SOCIAL AND ECONOMIC IMPACTS OF
AGRICULTURAL BIOTECHNOLOGY
The world economy is currently undergoing major structural changes. A 
central factor in these changes has been the development and diffusion of 
fundamentally new technologies, in particular computers and the “new 
biotechnologies.” Social and economic changes that result from these pro-
foundly enhanced capacities in science and
_______________          technology are visible in every sphere of human
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cation, to agriculture and the food supply. 
However, each change is associated not only 
with new benefits but also with new risks, latent 
complications and long term consequences 
which are often poorly understood. 
Commercial applications of biotechnology to 
agriculture are still in their infancy. Despite 
enormous optimism in the scientific commu-
nity, in national and state governments, and in 
the private sector, most of the products, pro-
cesses, and impacts of biotechnology, particu -
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fraught with concern and controversy within
both the scientific community and the broader 
public.
Often public concerns have centered on health 
and environmental safety issues. Similarly in 
Europe, the three standard criteria, human 
safety, animal safety, and efficacy, have been 
utilized to evaluate and approve new products
--------------------------          and processes. Currently, a fourth criterion, the
 social and economic effects of the product or 
technology is being proposed. This criterion has been employed for such 
actions as the European Common Market’s ban on growth hormones in
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food products. Recently, the Advocate General of the Court of Justice in 
the European Communities released his opinion on the legality of the hor-
mone ban stating that “It was appropriate and justifiable to prohibit the 
administration of the five substances for fattening purposes, even in the 
absence of scientific evidence showing that they were harmful. A total pro-
hibition was the only solution which could bring an end to the distortions 
of competition and barriers to intra-Community trade in meat, eliminate 
risk to public health, even if they were purely hypothetical ones, and avoid 
a further reduction in consumption.” (Weber, 1990:1)
Similar efforts are underway to utilize this approach as a precedent to 
alter the product approval process in the United States. Scientists, regula-
tors, industry representatives, and the public in general have all voiced 
concern that all technologies, including genetically engineered organisms 
and products, could have adverse impacts. As a result of these concerns 
and experiences with previous technologies, an increasingly accepted po-
sition among technology assessment professionals is that: 1 - all technolo-
gies have multiple effects; 2 - many of these effects are potentially harmful 
and thus require conscious decisions; and 3 - these critical decisions entail 
moral as well scientific analysis.
Although introduced as the fourth criterion, it may be more appropri-
ate in evaluating research agendas and new products and processes to con-
sider the broad socioeconomic effects as the first criterion. As most scien-
tists and policy analysts acknowledge, biotechnologies are the tools and 
means to achieve particular socioeconomic goals. As such they should be 
framed and evaluated in terms of those social goals and values.
In a democracy, the public has an obligation and a right to shape the de-
velopments of technology in terms of the broad social and economic val-
ues of their respective society. In the case of biotechnology, as we have 
seen, the public is increasingly exercising that obligation and right. There-
fore, it is important for scientists, regulators, and policy-makers to under-
stand and evaluate not only elements of human safety, animal safety, envi-
ronmental risk, and efficacy, but also the range of socioeconomic impacts 
and concerns.
The potential social and economic impacts of biotechnology on the 
food and fiber system and society are just emerging. Consequently, the 
proposed implications of biotechnology for the system represent only
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possible scenarios. The socioeconomic effects may include impacts on: 1 - 
science, 2 - farmers and rural communities, 3 - consumers, 4 - the struc-
ture of agribusiness and industry, and 5 - the global market and develop-
ing countries.
IMPACT ON SCIENCE
Perhaps the most dramatic immediate impact of the new biotechnologies 
has been on science itself. While some argue that biotechnology is a 
continuation of the application of biological techniques to improve 
plants, animal, and microorganisms, molecular biologists contend that 
“biotechnology has revolutionized biology and is destined to have even 
greater impact than the industrial revolution on agriculture and the food 
system in this country” (Harlander, etal, 1991).
The knowledge and tools generated by molecular biology and biotech-
nology have stimulated a great deal of enthusiasm and redirected large 
sums of money in an effort to pursue knowledge in this area. At the federal 
level, financial support for biotechnology has grown steadily since the mid 
1980s, reaching $3.8 billion in 1991. The President’s budget for 1992 calls 
for an 11 percent increase to $4.1 billion. While 80 percent of the federal 
budget has been devoted to the National Institutes of Health program, 
support for agricultural biotechnology has been relatively meager, consti-
tuting less than three percent of federal expenditures for biotechnology. 
There is, however, significant optimism that agricultural biotechnology 
will receive substantial increases at the federal level through the National 
Research Initiatives Program. In addition, industrial expenditures for bio-
technology research and development had grown to $2 billion by 1990, 
with a large portion of the expenditures devoted to agricultural biotech-
nology (Metheny and Monahan, 1991).
The techniques and tools of biotechnology are facilitating basic re-
search efforts to understand the intricate, complex, functioning of living 
organisms at their molecular and cellular level. Molecular biology in con-
junction with other basic research is accelerating the accumulation of 
knowledge in traditional disciplines such as biology, genetics, plant physi-
ology, and biochemistry. Moreover, biotechnology, particularly in agri-
culture, may truncate both the time and space required to develop new 
plant, animal, and food products. Finally, it may complement and extend
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tive impacts of Still, several potential negative impacts of molecular biology on science
molecular bi-       may exist. Biotechnology and molecular biology continue and extend the 
ology on sci-       basic methods and approaches of modern science. Their perspective, of- 
ence may exist,   ten called “logical positivism,” attempts to reduce nature to small, defin-
able pieces, subject to human manipulation and separated from broader 
questions of value. From this perspective, scientists control, measure, re-
duce, and divide nature in order to generate knowledge.
One concern is that this approach, while providing only partial knowl-
edge, has become the dominant epistemology, often to the exclusion of 
other important alternative ways of knowing. As a consequence, whole 
plant and animal level research, such as traditional plant breeding, and 
systems level research programs such as agroecology, farming systems, 
and social assessments, which should be important complements to a 
comprehensive biotechnology research agenda, receive inadequate sup-
port. In U.S. colleges of agriculture, for example, employment opportuni-
ties in agricultural biotechnology and molecular genetics are growing, 
while employment in plant and animal breeding is declining. Between 
1982 and 1988 full time equivalent (FTE) scientists conducting agricultural 
biotechnology research in the state agricultural experiment stations in-
creased by 259 percent (273 to 682). In addition, staff working in this area 
rose from 472 in 1982 to 1131 in 1988. At the same time, overall FTE faculty 
positions in the state agricultural experiment stations increased by only 65 
(National Association of State Universities and Land Grant Colleges, 
NASULGC, 1989). Therefore, much of the increase in the FTE’s for 
biotechnology research represented a reallocation of existing positions. 
Interviews with state agricultural experiment station directors confirmed 
this conclusion. They indicated that many of these molecular biology po-
sitions had been created by reducing the scope of conventional breeding 
programs (Busch, et al, 1991).
Another impact on science is the increase in the concentration of re-
search funds and scientific talent at a small number of public and private 
institutions. For example, in the public sector, every U.S. state could afford 
and has had a conventional breeding program. Every state cannot afford 
and will not be able to have a comprehensive agricultural biotechnology
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program. Instrumentation and annual funding costs are particularly ex-
pensive, with start-up funds and operating costs two to three times that of 
other agricultural sciences (NASULGC, 1989). Concentration of public 
sector and scientific talent in a few states is already occurring. While 33 
states are actively engaged in some promotion of biotechnology research 
and development, three states account for more than half the investment 
in biotechnology (Office of Technology Assessment, OTA, 1988). In agri-
cultural biotechnology eight states account for over half of the state ex-
periment station expenditures and nearly half of all science years for 
biotechnology research (NASULGC, 1989).
The new biotechnologies are also changing the division of labor be-
tween universities and industries with concomitant impacts. While part-
nerships between universities and industries have existed for several de-
cades, the new types of university and industry relationships in biotech-
nology (e.g., centers, institutes, research parks, public corporations) are 
more varied, more aggressive, and more experimental. They include: large 
grants and contracts between companies and universities in exchange for 
patent rights and exclusive licenses to discoveries; programs and centers, 
organized at major universities with industrial funds, that give participat-
ing private firms privileged access to university resources and a role in 
shaping research agendas; professors, particularly in the biomedical sci-
ences, serving in extensive consulting capacities on scientific advisory 
boards or in managerial positions of biotechnology firms; and faculty re-
ceiving research funding from private corporations in which they hold 
significant equity. In a recent survey of biotechnology researchers at 40 
major universities, 47 percent of these faculty consulted with outside cor-
porations and eight percent held equity in a firm whose products or ser-
vices were directly related to their own university research (Blumenthal, 
etal., 1986).
The consequences of these collaborations may be both positive and 
negative. First, these university and industry collaborations may bring 
useful products to market more rapidly and may promote U.S. techno-
logical leadership in a changing world economy. This has been a major 
motivation behind a number of recent funding policies and laws of the 
federal government requiring this collaboration for federally funded research. 
Second, in light of funding stagnation at both the federal and state levels,
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the collaborations are a means of raising new funds for university re-
search. Third, these joint efforts may expand the scientific network, in-
creasing communication between some industry and university scientists.
A number of concerns, however, have been raised regarding these new 
relationships. First, long term research, previously a major emphasis of 
the public sector, may decline. The private sector has short term propri-
etary goals, and, as a consequence, funding for research is also generally 
short term. A study in the mid-1980s of biotechnology firms revealed that 
nearly half funded research in universities. Of those funding research, 50 
percent reported that projects spanned one year or less, while only 25 per-
cent reported funding projects lasting more than two years (Blumenthal, 
etal, 1986). In contrast, nearly all of the NIH extramurally funded programs 
and the USDA Hatch formula funded projects are for three years or more.
A second issue is a potential restriction of communication. Proprietary 
agendas have begun to inhibit the flow of information among biotechnol-
ogy scientists and have raised concern about access to information. This is 
particularly true of university scientists with private sector grants, who of-
ten must delay public discussion of work, or its results, pending review by 
the sponsoring company. In one study 25 percent of industry sponsored 
biotechnology faculty, reported conducting research that belonged to the 
firm and could not be published without prior consent, while 40 percent 
reported that their collaboration resulted in unreasonable delays in pub-
lishing (Blumenthal, etal., 1986). Even some scientists with public fund-
ing feel inhibited about discussing their work, for fear that some private 
company with the money, equipment, and time will utilize their ideas and 
perform the experimental work before they can. The net effect of these 
various developments appears to be a reduction of the free flow of infor-
mation. Open communication is fundamental to public sector science, 
and indeed, one industry scientist remarked that more knowledge is gen-
erated by keeping an open environment for scientists (personal interview, 
1987). Most breakthroughs do not come from just one laboratory; instead 
there is need for more information from a number of different laborato-
ries. Communication among the scientists is crucial (OTA, 1986).
A third concern is a potential for conflict of interest or scientific mis-
conduct. In interviews both public and private sector scientists stressed 
the potentially detrimental effects of granting private patents for work
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done in the public sector. These effects include potential favoritism, un-
warranted financial advantage through privileged use of information or 
technology partly derived from publicly funded research, constraints on 
sharing of germplasm, and shelving of research which may be of interest 
to the public but not to the corporation (Lacy, et al, 1988).
Recently, Derek Bok in his final President’s report to Harvard 
University’s Board of Overseers warned that the commercialization of 
universities may be the most severe threat facing higher education. Mr.
Bok noted that as universities become “more entrepreneurial they appear 
less and less as charitable institutions seeking truth and serving students 
and more and more as huge commercial operations that differ from cor-
porations only because there are no shareholders and no dividends.” He 
concluded by saying that “it will take very strong leadership to keep the 
profit motive from gradually eroding the values on which the welfare and 
reputation of universities ultimately depend” (McMillen, 199KA31).
IMPACTS ON FARMERS AND RURAL COMMUNITIES
The impact of agricultural change on rural communities is to a high de-
gree proportional to the level of local dependence on agriculture. Today, 
nationwide, fewer than 40 congressional districts have more than 20 per-
cent of their population living on farms (Sundquist and Molnar, 1991).
The overwhelming majority of farms that once existed in the United States 
no longer exist and production is highly concentrated among the remain-
ing farms. The largest 13 percent of farms now produce over 75 percent of 
the value of total production. In addition, the vast majority of small farms 
are now buffered from the effects of technological change, since the farm is 
no longer the primary source of income for their owners. Consequently, 
biotechnology will probably have less impact on the total number of farms 
than previous mechanical and chemical technologies adopted by farmers 
during the last 50 years. Moreover, it is likely biotechnology will not 
greatly exacerbate the decline in the number of farms, although it will cer-
tainly maintain present trends which indicate that farming will continue 
to be one of the fastest declining occupations in the next decade (Bureau 
of Labor Statistics estimates 28 percent decline between 1990-2000).
The extent of biotechnology’s influence on the trend towards fewer and 
larger farms depends, in part, on how adoption affects the cost structure of
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farms. If biotechnology developments significantly alter costs, returns, 
competitive positions, and the special location of production, and if cer-
tain trade and farm policies are implemented, the potential impact of 
biotechnology could be relatively important. The Office of Technology 
Assessment (1986) has argued that these new technologies will be adopted 
by well financed, innovative farmers who are presumed to run the com-
paratively large farms. However, others have argued that biotechnology 
innovations will provide widespread benefits to the full range of farmers 
because new technologies will be used in traditional ways. Regardless of 
which farmers are likely to benefit, however, biotechnology will probably 
increase the value added off-farm at the expense of value added on-farm 
(Goodman, et al„ 1987).
Other significant changes in the farming community may result if the 
information and products of this technology bypass the Extension Service 
and agricultural cooperatives. Previous products and information of bio-
logical research have been disseminated through the Extension Service. 
However, the development of new seed-chemical packages through bio-
technology will emerge from private research, and public sector scientists 
will have limited knowledge with which to support extension programs. 
As a consequence, extension, and potentially agricultural cooperatives, 
may gradually be reduced to playing a secondary role in farm change. 
Moreover, many agriculturally based rural communities will continue the 
ongoing process of shrinkage and consolidation, as producers, and local 
supply and marketing firms continue to decline in numbers.
Biotechnology may also accelerate the trend toward contract integra-
tion, already common in the U.S., where commodities such as poultry and 
most processed vegetables are produced on contract. Such contracts 
specify the seeds, chemicals, planting and harvesting times and other as-
pects of farm production. These arrangements will further reduce the au-
tonomy of farmers and will certainly reduce their contact with and need 
for extension services, agricultural cooperatives and local farm suppliers. 
The new biotechnologies may also restructure the relationship between 
farmers and researchers. Until very recently farmers were seen as the pri-
mary clientele of public sector research. However, the entry of molecular 
biology into agricultural research has increasingly been accompanied by 
the insertion of the agribusiness sector between farmers and researchers.
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As a result it is quite possible that only problems of interest to the agri-
business sector will be the subject of public research agendas.
IMPACT ON CONSUMERS
The new biotechnologies expand and extend researchers’ ability to im-
prove plants, animals, and microorganisms. For consumers this could 
mean dramatic improvements in the productivity and efficiency of food 
production and processing and the expansion and extension of food and 
nonfood uses of raw agricultural commodities. Consumers could benefit 
in the form of reduced prices, increased food safety and more nutritional 
foods. The new technologies also have the potential to change the very 
nature of food itself and to expand the range of possible food products. 
With molecular biology it is possible to move genetic material among 
plants and between plants, animals, and microorganisms. It is now pos-
sible to consider the production of new fabricated foods in which basic 
foods are broken down into their component parts (e.g., starch, fat, and 
sugar) and recombined into wholly new types of food. Such new forms of 
food may not be desirable to consumers and may make it far more diffi-
cult in the future for the consumer to determine the composition of the 
food and to maintain a balanced diet.
Another impact of biotechnology has been the stimulation of new 
moral and ethical debates regarding the limits of science. Public concern 
about a range of scientific developments including biotechnology, are re-
sulting in a decline in public confidence in science and an increasing pub-
lic perception of a likelihood of environmental risks from genetically-al-
tered bacteria, plants and animals. The development of biotechnology is 
stimulating a wider range of concerns about science which extend beyond 
human health, environmental risk, food safety, and animal health issues 
and include such concerns as negative socioeconomic consequences and 
the morality of tampering with nature and life itself (Lacy, etal., 1991).
IMPACT ON AGRIBUSINESS
John Hardinger, Director of Biotechnology at Dupont’s Agricultural 
Products department, views biotechnology as a force to not only restruc-
ture farming but also to catalyze a major change in the structure of world-
wide agribusiness. He notes that the application of molecular biology
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permits the various segments of the world’s largest industrial sector to 
form logical linkages to other economic sectors that were never before 
practical. This 1.3 trillion dollar agribusiness sector (not counting feed 
and fiber) consists of the four basic elements: input suppliers, growers, 
processors and consumers. This system has experienced mechanical and 
chemical eras which contributed to increased productivity and efficiency. 
According to Hardinger the new biological and biotechnology era will fur-
ther increase both efficiency and productivity, as well as provide the ability 
to change the quality of food and feed. Furthermore, it will lead to con-
solidation and new forms of vertical integration of the food industry 
(Busch, et al., 1991).
The formation of new biotechnology companies increased dramatically 
from 1979 to 1983, with more than 250 small venture capital biotechnology 
firms founded in the U.S. Proliferation of these risk-taking companies 
helped raise billions of dollars from private investors and gave the U.S. a 
competitive lead in the early stages of biotechnology commercialization. 
By the late 1980s the number of these firms had grown to over 600. How-
ever, consolidation has begun in the industry with mergers, bankruptcies 
and major multinational corporation investments. Indeed, 80 percent of 
the funds in venture-capital firms have been invested in just ten compa-
nies (OTA, 1988).
In the early 1980s, multi-national corporations began to recognize the 
potential of biotechnology and to develop their own research and devel-
opment capacities. These corporations began diversifying into every field 
or specialty that used living organisms as a means of production. The new 
biotechnologies appeared to further reduce the distinctions among the 
traditional industrial sectors, rendering corporate boundaries virtually 
unlimited. Those large multinational corporations specializing in oil, 
chemicals, food, and pharmaceuticals have taken the leadership in agri-
cultural biotechnology research and development (e.g., American 
Cyanamid, Campbell Soup, Ciba Geigy, Dupont, Eli Lily, Monsanto, 
Rhone-Poulenc, R. J. R. Nabisco, Shell, Sandoz and Standard Oil). These 
corporations have also established research contracts, joint projects, ex-
clusive licensing and marketing, equity positions, and control or owner-
ship in the venture capital firms. By the late 1980s a small number of large 
multi-national corporations had significant positions in all the major
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biotechnology firms and provided over half of total funds being invested 
in developing this new technology (Busch, etal., 1991).
This concentration, accompanied by horizontal and vertical integration 
across industrial sectors, reflects the mergers, acquisitions and concentra-
tion in the food processing industries as traditionally nonfood industries 
dramatically expand their investments. This trend is also apparent in the 
input industries. Of the top seven pesticide corporations, five ranked 
among the world’s largest twenty seed companies with only Bayer and 
Dupont having marginal seed interests. Moreover, of the ten top seed 
companies, eight have significant interest in crop chemicals. Most analysts 
predict biotechnology will continue and accelerate this trend towards in-
creasing concentration of power in the hands of a small number of large 
multinational corporations.
Consequently, development and commercial control will be in the 
hands of corporations that transcend geographic boundaries and hold 
limited national allegiance. Within this context, people question how we 
can ensure that democratic participation will occur in the decision-mak-
ing processes surrounding the development and commercialization of 
biotechnology. This is difficult within national boundaries and generally 
prohibitive internationally, given current governmental structures.
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INTERNATIONAL IMPACTS
The new technologies offer the hope of increasing crop yields where popu-
lation growth is outstripping the food supply. In a recent parliament 
meeting in India, biotechnology was acknowledged as the lifeline for the 
whole of Indian agriculture, offering opportunities for increased sus-
tainability, profitability and international competitiveness (Ministry of 
Foreign Affairs, The Netherlands and the University of Amsterdam, 1990). 
Other nations have been equally optimistic regarding the prospects of ag-
ricultural biotechnology (Deo, et al, 1989).
It has been proposed that the direct use of molecular biology in con-
junction with plant propagation and breeding could dramatically increase 
crop productivity and overall food production in developing countries. 
Tissue culture techniques are already creating more drought and disease 
resistant varieties of cassava, oil palms, and groundnuts. Embryo transfer 
may raise the reproductive capacity of livestock. In Africa genetically engi -
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                                 neered vaccines and drugs may cure fatal or debilitating diseases (e.g., 
                                    onchoceriasis-river blindness, Guinea worm disease, schistosomiasis and 
                                  trypanosomiasis) thus opening up new agricultural and grazing areas 
                                 (Gibbons, 1990; Barker and Plucknett, 1991).
                                           Yet despite biotechnology’s great promise for feeding the world’s rap- 
                                            idly growing population, particularly in developing nations, science and 
                                  policy-makers admit it will not be easy to ensure that this technology has 
                                           the desired positive effects. First, there is legitimate concern that the devel- 
                                  oped nations will use their technology to undercut traditional Third 
                                     World exports, such as sugar, vanilla, cocoa butter, and other important 
                                 cash crops. Genetic engineering is already being applied to bacteria, yeast 
         and fungi to produce starter cultures with specific metabolic capabilities
in food fermentation. These processes, combined with the new cell culture 
techniques, are being used to transform the production of certain agricul-
tural commodities into industrial processes. In principle, any commodity 
that is consumed in an undifferentiated or highly processed form could be 
produced in this manner and product substitutions could be easily intro-
duced. Similarly, although with greater difficulty, tissue culture tech-
niques could be used to produce edible plant parts in vitro. In short, agri-
cultural production in the field could be supplanted by cell and tissue cul-
ture factories (Busch, et al., 1991).
Several companies are now capable of phytoproduction of a natural va-
nilla product in the laboratory. A genetic modification of oilseed plants to 
convert cheap oils (e.g. palm or soybean oil) into high quality cocoa butter 
is well advanced. Biotechnology is also being used to produce substitutes 
for sugar as an industrial sweetener. Several major corporations in the 
U.S. and Europe, (e.g., Unilever and Ingene) are attempting to use recom-
binant DNA technology to produce the thaumatin protein, one of the 
sweetest known substances. Successful development of a thaumatin prod-
uct through genetic engineering may continue a transition to alternative 
sweeteners, eliminating the market for beet and cane sugar and capturing 
the valuable sweetener market. Even moderate success in realizing these 
product substitutions would have profound effects around the world, 
most immediate and important would be the restructuring of global mar-
kets (Persley, 1990).
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Another issue focuses on environmental risks. Because the environ-
mental release of genetically modified organisms may have hazardous 
effects on the ecosystem, in many of the industrialized countries the public 
has pressed for the adoption of safety regulations. These regulations, how-
ever, may restrict biotechnology experiments. As a consequence, research-
ers and biotechnology companies are attempting to relocate their experi-
ments to countries with limited or no safety regulations. This may result 
in the movement of possibly hazardous biotechnology experiments to 
Third World countries.
A further concern is that biotechnology will increase the disparities be-
tween the developed and developing nations. With the shift in applied re-
search and associated product development from the public to the private 
sector, the benefits from the new biotechnologies may become less widely 
available. Moreover, the products developed are unlikely to be ones which 
are important to the poor developing countries, particularly in the trop-
ics. Biotechnology research has emphasized temperate zone animal repro-
duction, breeding, veterinary health care and animal nutrition, and tem-
perate zone plant improvement. Little or no work is currently being di-
rected at transformation of tropical crops important to developing coun-
tries. This could further widen the gap between the agriculture produc-
tion methods in the North and the less advanced practices in the South 
(Deo, etal, 1989).
The Third World might be able to counter these technological develop-
ments by enhancing its own scientific capabilities. But this is unlikely to 
occur. Many developing countries have no basic research capacity, limited 
capabilities to adapt biotechnological advances to local conditions, and 
few resources to attract transnational corporations.
In conclusion, agricultural biotechnology may shift the geographic lo-
cation of agricultural production from one Third World country to an-
other or from the Third World to the First World. For many Third World 
countries, dependent on one or two agricultural commodities for their 
continued viability, this production and market restructuring and in-
creased productivity gaps could result in a collapse in existing markets. 
Significant numbers of farmers and farm workers could find themselves 
with no products to sell. This could increase the already high Third World 
debt and exacerbate the deficit in balance of payments in Third World
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countries. Political instability, already a problem in the developing world, 
would doubtless increase.
The effects of these possible changes in the patterns of world trade are 
also likely to be felt in the West. With developing countries experiencing 
economic deterioration they could no longer serve as a main market for 
developed country exports, creating economic and social stress in the de-
veloped nations as well. For the continued well-being of an increasingly 
global economy, a conscientious effort must be made to help developing 
nations acquire the appropriate technology, establish and maintain an in-
frastructure for support of applied research, and improve their capacity to 
evaluate this new technology in terms of their own public good.
CONCLUSION
Addressing issues relative to the new biotechnologies at this early stage 
offer us an opportunity to assess these technologies before they actually 
exist and to examine the alternative paths for their development. Al-
though changes and developments are proceeding rapidly, they are nei-
ther inevitable nor totally shaped. As Winner (1986:29) observed “By far 
the greatest latitude of choice exists the very first time a particular instru-
ment, system or technique is introduced.” The ultimate direction this 
technology takes will be determined by the actors who participate in its 
development.
This paper has discussed a number of both positive and negative social 
and economic impacts biotechnology may have on science, farms and ru-
ral communities, consumers, agribusiness, global markets and the inter-
national community. We suggest that biotechnology may increase inequi-
ties not only among various groups in our society, but also between devel-
oped and developing countries and among the more and less advanced 
developing countries. These potential impacts raise complex ethical and 
policy questions. A more careful review and monitoring of the scientific 
developments is essential, and a more detailed assessment of the fourth 
criterion, the social and economic impacts of particular technological 
changes, is needed. Further, we need to incorporate the fourth criterion 
into our decision-making and develop policies and long-range planning 
capacities to address the potential scenarios. Finally, we need to balance
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research programs, nationally and globally, in terms of time frame, pro-
prietary nature and level of analysis (molecular, cellular, species and sys-
tem) to ensure an agenda that is environmentally sound, enhances our 
health and focuses on building sustainability in both our fields and com-
munities. Whose needs and goals will be served and whose neglected are 
perhaps the most important agricultural and social questions of the com-
ing decade.
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